Collegium Pharmaceutical, Inc. (COLL)
Collegium Pharmaceutical, Inc. (COLL) Insider Trading
Directors, officers and holders of more than 10% of COLL report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 122 transactions on file: 0 with code P, 12 with code S and 38 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | SANTINI GINO | Director | M Exercise | 8,700 | Not measured | Not measured |
| Jun 8, 2026 | SANTINI GINO | Director | M Exercise | 8,700 | $16.49 | $143,463 |
| May 18, 2026 | Freund John Gordon | Director | S Sale | 20 | $34.05 | $681 |
| May 15, 2026 | Freund John Gordon | Director | M Exercise | 8,700 | $16.49 | $143,463 |
| May 15, 2026 | Freund John Gordon | Director | M Exercise | 8,700 | Not measured | Not measured |
| May 15, 2026 | Freund John Gordon | Director | S Sale | 4,127 | $34.54 | $142,547 |
| May 14, 2026 | Glancy Donovan Michael | Director | A Award | 17,482 | Not measured | Not measured |
| May 14, 2026 | Freund John Gordon | Director | A Award | 8,741 | Not measured | Not measured |
| May 14, 2026 | Balice-Gordon Rita J. | Director | A Award | 8,741 | Not measured | Not measured |
| May 14, 2026 | SANTINI GINO | Director | A Award | 8,741 | Not measured | Not measured |
| May 14, 2026 | BOHLIN GAREN G | Director | A Award | 8,741 | Not measured | Not measured |
| May 14, 2026 | Paya Carlos V | Director | A Award | 8,741 | Not measured | Not measured |
| May 14, 2026 | Lurker Nancy | Director | A Award | 8,741 | Not measured | Not measured |
| May 13, 2026 | Lurker Nancy | Director | S Sale | 4,500 | $35.97 | $161,861 |
| May 11, 2026 | BOHLIN GAREN G | Director | M Exercise | 8,700 | Not measured | Not measured |
| May 11, 2026 | BOHLIN GAREN G | Director | M Exercise | 8,700 | $16.49 | $143,463 |
| May 11, 2026 | BOHLIN GAREN G | Director | S Sale | 8,700 | $37.18 | $323,491 |
| Mar 18, 2026 | Dieter David | EVP & General Counsel | S Sale | 13,976 | $34.92 | $488,099 |
| Mar 17, 2026 | Dieter David | EVP & General Counsel | F Tax Payment | 8,840 | $35.72 | $315,765 |
| Mar 9, 2026 | Dieter David | EVP & General Counsel | S Sale | 6,224 | $36.65 | $228,110 |
| Mar 3, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | S Sale | 3,559 | $40.99 | $145,879 |
| Mar 3, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | S Sale | 46,417 | $40.36 | $1,873,557 |
| Feb 10, 2026 | Karnani Vikram | President and CEO | A Award | 79,264 | Not measured | Not measured |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | A Award | 14,268 | Not measured | Not measured |
| Feb 10, 2026 | Dieter David | EVP & General Counsel | A Award | 9,005 | Not measured | Not measured |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | A Award | 22,774 | Not measured | Not measured |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | F Tax Payment | 9,977 | $46.75 | $466,425 |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | F Tax Payment | 5,897 | $46.75 | $275,685 |
| Feb 10, 2026 | Smith Thomas B | EVP and Chief Medical Officer | F Tax Payment | 11,538 | $46.75 | $539,402 |
| Feb 10, 2026 | Dieter David | EVP & General Counsel | A Award | 22,194 | Not measured | Not measured |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | F Tax Payment | 26,679 | $46.75 | $1,247,243 |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | F Tax Payment | 11,861 | $46.75 | $554,502 |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | A Award | 32,734 | Not measured | Not measured |
| Feb 10, 2026 | Tupper Colleen | EVP & Chief Financial Officer | A Award | 26,421 | Not measured | Not measured |
| Feb 10, 2026 | Karnani Vikram | President and CEO | F Tax Payment | 11,296 | $46.75 | $528,088 |
| Feb 10, 2026 | Karnani Vikram | President and CEO | A Award | 32,531 | Not measured | Not measured |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | A Award | 19,023 | Not measured | Not measured |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | A Award | 30,702 | Not measured | Not measured |
| Feb 10, 2026 | Dieter David | EVP & General Counsel | F Tax Payment | 2,781 | $46.75 | $130,012 |
| Feb 10, 2026 | Dreyer Scott | EVP & Chief Commercial Officer | F Tax Payment | 21,615 | $46.75 | $1,010,501 |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M Exercise | 17,600 | $15.90 | $279,840 |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S Sale | 11,125 | $47.89 | $532,771 |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | S Sale | 6,475 | $48.66 | $315,085 |
| Dec 8, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | M Exercise | 17,600 | Not measured | Not measured |
| Dec 5, 2025 | Balice-Gordon Rita J. | Director | S Sale | 3,650 | $47.03 | $171,673 |
| Nov 12, 2025 | Fallon John A. | Director | M Exercise | 19,853 | $9.33 | $185,228 |
| Nov 12, 2025 | Fallon John A. | Director | M Exercise | 19,853 | Not measured | Not measured |
| Nov 12, 2025 | Fallon John A. | Director | M Exercise | 15,000 | $16.49 | $247,350 |
| Nov 12, 2025 | Karnani Vikram | President and CEO | F Tax Payment | 8,983 | $47.35 | $425,345 |
| Nov 12, 2025 | Fallon John A. | Director | S Sale | 34,853 | $47.21 | $1,645,536 |
The full Form 4 history is on the COLL company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.